Hyperoxaluria clinical trials at UCSF

1 in progress, 0 open to eligible people

Long Term Extension Study in Patients With Primary Hyperoxaluria
Sorry, accepting new patients by invitation only
The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (<18 years old) long-term access to DCR-PHXC, and to evaluate the long-term safety and efficacy of DCR-PHXC in patients with PH.
San Francisco, California and other locations

Last updated: June 2022